Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Conservative Versus Surgical Management of Idiopathic Normal Pressure Hydrocephalus (INPH)
This study is currently recruiting participants.
Verified by University College London Hospitals, July 2008
Sponsored by: University College London Hospitals
Information provided by: University College London Hospitals
ClinicalTrials.gov Identifier: NCT00727142
  Purpose

This study aims to provide class 1 evidence supporting or refuting the existence of normal pressure hydrocephalus.


Condition Intervention
Normal Pressure Hydrocephalus
Procedure: Surgical treatment
Procedure: Conservative Treatment

MedlinePlus related topics: Hydrocephalus
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Active Control, Parallel Assignment
Official Title: Conservative Versus Surgical Management of Idiopathic Normal Pressure Hydrocephalus

Further study details as provided by University College London Hospitals:

Primary Outcome Measures:
  • improvement in walking speed [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • improved cognition or continence [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: July 2008
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
a: Active Comparator Procedure: Surgical treatment
Insertion of a functioning shunt
b: Placebo Comparator Procedure: Conservative Treatment
Placebo effect

Detailed Description:

By comparing one group with active CSF shunting with another with non .

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Idiopathic Normal pressure Hydrocephalus

Exclusion Criteria:

  • Alzheimer disease
  • Vascular dementia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00727142

Contacts
Contact: Laurence Watkins, FRCS 020 7837 3611 ext 4158 laurence.watkins@uclh.nhs.uk
Contact: Ahmed Toma, FRCS 020 7837 3611 ext 3225 ahmed.toma@uclh.nhs.uk

Locations
United Kingdom
National Hospital for Neurology and Neurosurgery Recruiting
London, United Kingdom, WC1N 3BG
Principal Investigator: Laurence Watkins, FRCS            
Sub-Investigator: Ahmed Toma, FRCS            
Sponsors and Collaborators
University College London Hospitals
Investigators
Principal Investigator: Laurence Watkins, FRCS NHNN
  More Information

Responsible Party: National Hospital for Neurology and Neurosurgery/Queen Square ( Mr Laurence Watkins )
Study ID Numbers: 08/0149
Study First Received: July 29, 2008
Last Updated: July 29, 2008
ClinicalTrials.gov Identifier: NCT00727142  
Health Authority: United Kingdom: National Health Service

Keywords provided by University College London Hospitals:
NPH
Hydrocephalus
Shunt

Study placed in the following topic categories:
Pseudotumor cerebri
Pseudotumor Cerebri
Infant, Newborn, Diseases
Central Nervous System Diseases
Hydrocephalus, Normal Pressure
Hydrocephalus
Brain Diseases
Intracranial Hypertension
Hypertension

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 14, 2009